Variant:
rs35742686 at chr22:42524244 in CYP2D6 (VIP)

Alleles (on + chromosomal strand)
T > -
Amino Acid Translation
Alternate Names:
c.622delA, c.775delA, g.21914813delT, g.2708delA, g.27275delA, g.7640delA, p.Arg208fx, p.Arg259fx
Haplotypes
This variant is used to determine: CYP2D6*3

VIP Variant in CYP2D6

CYP2D6 2549 del A (also known as 2637 del A in the literature) causes a frameshift mutation that results in a truncated, non-functional protein. CYP2D6 2549 del A was first cloned from a genomic library of a PM by Kagimoto et al. [Article:2211621], and is the diagnostic SNP for the CYP2D6*3 haplotype [Article:10634130]. CYP2D6 2549 del is essentially only found in Caucasian populations [Article:9241659].

Note: The CYP2D6 gene is found on the minus chromosomal strand. Please note that for standardization, the PharmGKB presents all allele base pairs on the positive chromosomal strand, therefore the alleles within our variant annotations will differ (in a complementary manner) from those in this VIP summary that are given on the minus strand as reported in the literature.

Key Publications:
Drugs / Other Molecules
Diseases Cystic Fibrosis Depression Hypertension Neoplasms Pain Parkinson Disease Schizophrenia
Phenotype Datasets Hot flashes in tamoxifen patients
Lipid measurements in tamoxifen study
Lipid measurements in tamoxifen study - set 2
Meperidine N-demethylation by human CYP450 isoforms
Metabolism of yohimbine by human CYP450 isoforms
Patient responses to tamoxifen
Pharmacokinetics of Tamoxifen at 4 months
Thyroid binding globulin in tamoxifen patients

Appendix

CYP2D6: 2549 del A

Genomic Variant & GenBank ID: 4168 del A on M33388
mRNA Variant & GenBank ID: A775 del on X08006
Protein Variant & GenBank ID: frameshift
GoldenPath Position: chr22:40854188 on hg 18
DNA Source Containing
Homozygous Reference
Allele(Coriell Lines):
GM17021
DNA Source Containing
Heterozygous
Reference
Allele (Coriell Lines):
GM17024
Key Haplotypes: CYP2D6*3

Connected Drugs

Connected Diseases

Publications related to rs35742686 at chr22:42524244: 3

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics. 1999. Gaedigk A, et al. [Article:10634130@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997. Marez D, et al. [Article:9241659@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. The Journal of biological chemistry. 1990. Kagimoto M, et al. [Article:2211621@PubMed]

Cross-References

UCSC Golden Path:
chr22:42524244
dbSNP:
rs35742686
ALFRED:
SI015495Y

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.